Cargando…

Safety of PPAR Agonists

Detalles Bibliográficos
Autor principal: Home, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632164/
https://www.ncbi.nlm.nih.gov/pubmed/21525458
http://dx.doi.org/10.2337/dc11-s233
_version_ 1782266852240523264
author Home, Philip
author_facet Home, Philip
author_sort Home, Philip
collection PubMed
description
format Online
Article
Text
id pubmed-3632164
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-36321642013-04-24 Safety of PPAR Agonists Home, Philip Diabetes Care Diabetes Treatments American Diabetes Association 2011-05 2011-04-22 /pmc/articles/PMC3632164/ /pubmed/21525458 http://dx.doi.org/10.2337/dc11-s233 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Diabetes Treatments
Home, Philip
Safety of PPAR Agonists
title Safety of PPAR Agonists
title_full Safety of PPAR Agonists
title_fullStr Safety of PPAR Agonists
title_full_unstemmed Safety of PPAR Agonists
title_short Safety of PPAR Agonists
title_sort safety of ppar agonists
topic Diabetes Treatments
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632164/
https://www.ncbi.nlm.nih.gov/pubmed/21525458
http://dx.doi.org/10.2337/dc11-s233
work_keys_str_mv AT homephilip safetyofpparagonists